Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids

Gut

Volumn 39, Issue 5, 1996, Pages 661-667

  Koop, I ^d   Schindler, M ^a   Bosshammer A ^a   Scheibner, J ^c   Stange, E ^c   Koop, H ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bile; Bile acids; CCK A receptor antagonist; Cholecystokinin; Pancreatic enzyme secretion; Pancreatic polypeptide

Indexed keywords

BILE ACID; BILIRUBIN; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; LOXIGLUMIDE; PANCREAS ENZYME; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME RELEASE; HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030462843     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.5.661     Document Type: Article

References (26)

1. Forell MM, Otte M, Kohl HJ, Lehnen P, Stahlheber HP. The influence of bile and pure bile salts on pancreatic secretion in man. Scand J Gastroenterol 1971; 6: 261-6.
2. Björnssen OG, Maton PN, Fletcher DR, Chadwick VS. Effects of duodenal perfusion with sodium taurocholate on biliary and pancreatic secretion in man. Eur J Clin Invest 1982; 12: 97-105.
3. Riepl RL, Lehnert P, Scharl A, Hempen I, Fiedler F, Teufel J, et al. Effect of intraduodenal bile and Nataurodeoxycholate on exocrine pancreatic secretion and on plasma levels of secretin, pancreatic polypeptide, and gastrin in man. Scand J Gastroenterol 1990; 25: 45-53.
4. Koop I, Dorn S, Koop H, Witzleb S, Beglinger C, Schafmayer A, et al. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans. Dig Dis Sci 1991; 36: 1625-32.
5. Malagelada JR, Go VLW, DiMagno EP, Summerskill WHJ. Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function. J Clin Invest 1973; 52: 2160-5.
6. Malagelada JR, DiMagno EP, Summerskill WHJ, Go VLW. Regulation of pancreatic and gallbladder functions by intraluminal fatty acids and bile acids in man. J Clin Invest 1976; 58: 493-9.
7. Schmidt WE, Creutzfeldt W, Schleser A, Roy Choudhury A, Hustede R, Höcker M, et al. Role of cholecystokinin in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol 1991; 260: G197-G206.
8. Hildebrand P, Beglinger C, Gyr K, Jansen JBMJ, Rovati LC, Zuercher M, et al. Effects of cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990; 85: 640-6.
9. Gomez G, Upp JR, Lluis F, Alexander RW, Poston GJ, Greely GH, et al. Regulation of the release of cholecystokinin by bile salts in dogs and humans. Gastroenterology 1988; 94: 1036-46.
10. Koop I, Koop H, Gerhardt C, Schafmayer A, Arnold R. Do bile acids exert a negative feedback control on plasma-CCK release? Scand J Gastroenterol 1989; 24: 315-20.
11. Schmidt WE, Creutzfeldt W, Höcker M, Nustede R, Roy Choudhury A, Schleser A, et al. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Eur J Clin Invest 1991; 21: 501-11.
12. Wildgrube HJ, Stockhausen H, Petri J, Fussel U, Lauer H. Naturally occurring conjugated bile acids, measured by high-performance liquid chromatography, in human, dog, and rabbit bile. J Chromatogr. 1986; 353: 207-13.
13. Janowitz P, Swobodnik W, Wechsler JG, Zöller A, Kuhn K, Ditschuneit H. Comparison of gallbladder bile and endoscopically obtained duodenal bile. Gut 1990; 31: 1407-10.
14. Setnikar I, Bani M, Cereda R, Chisté R, Macovec F, Pacini MA, et al. Pharmacological characterisation of a new potent and specific nonpolypeptidergic cholecystokinin antagonist. Arzneimindforschung 1987; 37: 703-7.
15. Semikar I, Bani M, Cereda R, Chisté R, Macovec F, Pacini MA, et al. Anticholecystokinin activities of loxiglumide. Arzneiminelforschung 1987; 37: 1168-71.
16. Swobodnik W, Kluppelberg U, Wechsler JG, Volz M, Normandin G, Ditschuneit H. Rapid and accurate reversed-phase high-performance liquid chromatographic determination of conjugated bile acids in human bile for routine clinical applications. J Chromatogr 1985; 339: 163-7.
17. Hummel BCW. A modified spectrophotometric determination of chymotrypsin, trypsin and thrombin. Can J Biochem Physiol 1959; 37: 1393-9.
18. Hyden S. A turbidimetric method for the determination of higher polyethylene glycols in biological materials. Kungl Lantbrukshoegsk Ann 1956; 22: 139-45.
19. Schafmayer A, Werner M, Becker HD. Radioimmunological determination of cholecystokinin in tissue extracts. Digestion 1982; 24: 146-54.
20. Schwartz TW, Stadil F, Chance RE, Rehfeld JF, Larrson LI, Moon N. Pancreatic polypeptide response to food in duodenal ulcer patients before and after vagotomy. Lancet 1976; i: 102-5.
21. Stern DH, Walsh JH. Gastrin release in postoperative ulcer patients: evidence of release of duodenal gastrin. Gastroenterology 1973; 64: 363-9.
22. Daniel WW. Applied nonparametric statistics. PWS Kent ISE, 1990.
23. You CH, Pominger JM, Chey WY. Potentiation effects of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. Gastroenterology 1983; 85: 40-4.
24. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A. Cholecystokinin is a regulator of intestinal phase-stimulated PP release. Regulatory Peptides 1990; 30: 105-11.
25. Koide M, Okabayashi Y, Otsuki M. Role of endogenous bile on basal and postprandial CCK release in humans. Dig Dis Sci 1993; 38: 1284-90.
26. Koop I, Fellgiebel A, Koop H, Schafmayer A, Arnold R. Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion. Eur J Clin Invest 1988; 18: 517-23.